A review of the evidence for malignant and non-malignant respiratory disease prescriptions commissioned by the Industrial Injuries Advisory Council (IIAC)

No government response; none expected. This is a scientific evidence review (Phase 3 summary by the Institute of Occupational Medicine/HSE authors) commissioned by the Industrial Injuries Advisory Council, an independent statutory advisory body, to inform whether IIAC should recommend changes to prescribed industrial diseases. It states it does not represent government policy. Government responds to IIAC's eventual recommendations (typically a Command Paper), not to the underlying evidence review.